Cathcart ES; Shirahama T; Cohen AS (1967). ”Isolation and identification of a plasma component of amyloid”. Biochim. Biophys. Acta 147 (2): sid. 392–393. doi:10.1016/0005-2795(67)90420-5.
”Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene”. Nature Medicine 3 (8): sid. 855–9. August 1997. doi:10.1038/9544. PMID 9256275.
”Imaging amyloidosis with radiolabelled SAP”. European Journal of Nuclear Medicine 22 (7): sid. 595–9. July 1995. doi:10.1007/BF01254559. PMID 7498219.
”Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis”. Nature 417 (6886): sid. 254–9. May 2002. doi:10.1038/417254a. PMID 12015594.
”Structure of pentameric human serum amyloid P component”. Nature 367 (6461): sid. 338–45. January 1994. doi:10.1038/367338a0. PMID 8114934.
”Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene”. Nature Medicine 3 (8): sid. 855–9. August 1997. doi:10.1038/9544. PMID 9256275.
”Imaging amyloidosis with radiolabelled SAP”. European Journal of Nuclear Medicine 22 (7): sid. 595–9. July 1995. doi:10.1007/BF01254559. PMID 7498219.
”Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis”. Nature 417 (6886): sid. 254–9. May 2002. doi:10.1038/417254a. PMID 12015594.
”Structure of pentameric human serum amyloid P component”. Nature 367 (6461): sid. 338–45. January 1994. doi:10.1038/367338a0. PMID 8114934.